| Short Description : | Recombinant-Cynomolgus TNFRSF17/BCMA/CD269-C-hFc protein was developed in hek293 cells using the region Met1-Ala53. For use in research applications. |
| Host: | HEK293 cells |
| Note: | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Conjugation: | Unconjugated |
| Formulation: | Lyophilised from a 0.2 Mu m filtered solution of PBS, pH 7.4.Contact us for customized product form or formulation. |
| Storage Instruction: | Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Determination Method: | < 0.1 EU/Mu g of the protein by LAL method. |
| Immunogen: | Recombinant Human Angiopoietin-2/ANGPT2 Protein is produced by mammalian expression system. The target protein is expressed with sequence (Met1-Ala53) of cynomolgus BCMA (Accession #G7Q0I4) fused with an Fc tag at the C-terminus. |
| Immunogen Region: | Met1-Ala53 |
| Immunogen Sequence: | MLQMARQCSQNEYFDSLLHD CKPCQLRCSSTPPLTCQRYC NASMTNSVKGMNA |
| Background | B-cell maturation antigen (BCMA or BCM) , also known as tumor necrosis factor receptor superfamily member 17 (TNFRSF17) , is a protein that in humans is encoded by the TNFRSF17 gene.TNFRSF17 is a cell surface receptor of the TNF receptor superfamily which recognizes B-cell activating factor (BAFF). |
Information sourced from Uniprot.org
